Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
INSM > SEC Filings for INSM > Form 8-K on 13-Nov-2012All Recent SEC Filings

Show all filings for INSMED INC

Form 8-K for INSMED INC


13-Nov-2012

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On November 13, 2012, Insmed Incorporated (the "Company") issued a press release announcing the completion of target enrollment for the Company's pivotal CLinical Evaluation of ARIKACE phase 3 study (CLEAR-108) of ARIKACEŽ (liposomal amikacin for inhalation) in Europe and Canada for Cystic Fibrosis (CF) patients with Pseudomonas aeruginosa (Pa) lung infections.

A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1 Press release issued by Insmed Incorporated dated November 13, 2012.


  Add INSM to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for INSM - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.